Sartorius Stedim Biotech S.A. (SDMHF)
OTC
Closed
Aug 24, 2026
Day's Range
210.0052 wk Range
178.30Overview - SDMHF - Sartorius Stedim Biotech S.A.
Key Statistics
Valuation
Enterprise Value
27.13B
P/E (Trailing)
‪61.67‬
PEG Ratio
‪6.78‬
Price / Sales (TTM)
‪7.02‬
Price / Book
‪4.29‬
EV / EBITDA
‪28.46‬
Profitability
Gross Margin
‪46.85%‬
Profit Margin
‪9.73%‬
Operating Margin
‪20.11%‬
Return on Assets
‪4.39%‬
Return on Equity
‪7.08%‬
Ownership
Shares Outstanding
97.29M
Float
27.61M
Held by Insiders
‪71.50%‬
Held by Institutions
‪11.75%‬
Price stats
Beta
‪1.13‬
50-Day Avg
‪202.77‬
200-Day Avg
‪212.67‬
Dividends
Payout Ratio
‪22.92%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SDMHF - Sartorius Stedim Biotech S.A.
Peers - SDMHF - Sartorius Stedim Biotech S.A.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on OTC.
Profile Summary - SDMHF - Sartorius Stedim Biotech S.A.
About
Sartorius Stedim Biotech S.A. is a leading international provider of innovative equipment and services for the biopharmaceutical industry and life sciences research. The company specializes in single-use technologies, laboratory instruments, consumables, and bioprocess solutions that support the development, quality…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
